ArticleFrontiers in oncology2024

A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma.

Jeong-Yeon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.